Allele
An allele (or allelomorph) is one of two or more alternative nucleotide sequence variants of a gene or non-coding genetic locus occupying the same physical position on homologous chromosomes.
Allele (shortened from allelomorph, coined by William Bateson and Edith Rebecca Saunders in 1902 from the Greek *allēlon*, meaning "of one another") is one of two or more alternative DNA sequence variants of a specific gene or non-coding genomic region that occupy the identical physical position—known as a genetic locus—on a pair of homologous chromosomes. In sexually reproducing diploid organisms such as humans, somatic cells carry two homologous sets of chromosomes (one inherited maternally via the oocyte and one inherited paternally via the spermatozoon) and therefore possess two alleles at every autosomal locus. When both alleles at a given locus have identical nucleotide sequences, the organism is homozygous at that locus; when the two alleles differ by one or more single-nucleotide polymorphisms (SNPs), insertions, deletions, or structural rearrangements arising from mutation, the organism is heterozygous.
Molecular Architecture: How Do Sequence Variants Create Functional Alleles?
While Gregor Mendel originally conceptualized alleles in 1865 as abstract, indivisible particulate "elements" (*Merkmale*) governing binary traits such as smooth versus wrinkled pea seeds, modern molecular genetics defines an allele at atomic resolution as a specific sequence of nucleotides spanning a gene's regulatory promoters, enhancers, protein-coding exons, and intervening introns.
New alleles originate through spontaneous or induced mutations during DNA replication, meiotic recombination, or mobile element transposition. Depending on how a sequence change alters the expression level, stability, or catalytic activity of the encoded RNA or protein product, geneticists classify mutant alleles relative to the prevalent reference (wild-type) allele using Hermann Joseph Muller's 1932 morphic nomenclature:
| Mullerian Allele Class | Molecular Mechanism | Effect on Protein Activity | Classical Dominance Behavior | Canonical Human / Model Example |
|---|---|---|---|---|
| Amorph (Null Allele) | Nonsense mutation, frameshift deletion, or splice-site destruction completely abolishes protein synthesis or catalysis | 0% functional activity (complete loss-of-function) | Typically recessive (if 50% enzyme suffices) or dominant via haploinsufficiency | *CFTR* p.Phe508del or nonsense alleles in cystic fibrosis; *O* blood group glycosyltransferase frameshift |
| Hypomorph (Leaky Allele) | Missense mutation reducing enzyme *k*cat/stability, or promoter/splicing mutation lowering mRNA output | 5%–50% reduced functional activity (partial loss-of-function) | Typically recessive; causes milder phenotypes than null homozygotes | *SMN2* exon 7 skipping allele in spinal muscular atrophy; mild β+-thalassemia splice alleles |
| Hypermorph | Promoter/enhancer activating mutation, gene duplication, or loss of an autoinhibitory protein domain | >100% elevated activity or constitutive signaling (gain-of-function) | Dominant | *FGFR3* p.Gly380Arg constitutive kinase activation in achondroplasia dwarfism |
| Antimorph (Dominant-Negative) | Mutant subunit lacks catalytic function but still dimerizes/multimerizes with wild-type subunits, poisoning the entire complex | Reduces heterozygote activity well below 50% (often to 6.25%–25% in tetramers/polymers) | Strongly dominant | *COL1A1* glycine substitutions poisoning triple-helical collagen fibrils in osteogenesis imperfecta; *TP53* tetramer mutations |
| Neomorph | Missense mutation or chromosomal translocation creates an entirely novel biochemical function or toxic aggregate | Novel substrate specificity, ectopic expression, or amyloid polymerization | Dominant | *HTT* CAG polyglutamine expansion in Huntington's disease; *IDH1* Arg132His producing 2-hydroxyglutarate in gliomas |
Dominance Relationships: Why Are Some Alleles Dominant and Others Recessive?
A persistent misconception in introductory biology is that "dominant alleles are stronger, physically repress recessive alleles, or are always more common in populations." In reality, dominance is not an intrinsic property of a DNA sequence alone; it is an emergent physiological property of how a heterozygote (*A/a*) phenotype compares to the two homozygote (*A/A* and *a/a*) phenotypes across a biochemical pathway.
Complete Dominance and Kacser–Burns Metabolic Control Theory
Why are the vast majority of loss-of-function (amorphic or hypomorphic) enzyme mutations recessive to the wild-type allele? In 1981, Henrik Kacser and Jim Burns resolved the molecular basis of Mendel's Law of Dominance using metabolic control analysis. Most cellular traits (such as pigment biosynthesis or nutrient catabolism) are produced by multi-step enzymatic pathways containing 5 to 15 enzymes acting in series. Because the total metabolic flux (*J*) through a pathway is shared across all enzymes, the relationship between the concentration of any single enzyme (*E*i) and the final metabolic flux follows a concave hyperbolic curve with diminishing returns.
In a wild-type homozygote (*A/A*) with 100% enzyme dose, the pathway operates on the flat plateau of the hyperbola with a large safety margin (haplosufficiency). In a heterozygote (*A/a*) carrying one wild-type allele and one null allele, the cell synthesizes exactly 50% of the normal enzyme concentration, yet the total metabolic flux remains at ~90% to 98% of normal—producing a wild-type phenotype indistinguishable from *A/A*. Only in the homozygous mutant (*a/a*, 0% enzyme) does flux collapse to zero. For instance, in Mendel's pea plants (*Pisum sativum*), the wild-type *R* allele encodes starch-branching enzyme I (SBEI); *R/r* heterozygotes synthesize 50% SBEI enzyme, which still synthesizes enough branched amylopectin to prevent osmotic water influx and yield perfectly round seeds, whereas *r/r* homozygotes (disrupted by a 0.8-kb transposon insertion) accumulate sucrose, swell with water, and shrink into wrinkled seeds upon drying.
Conversely, a loss-of-function allele behaves as a dominant trait when 50% of the gene product is insufficient for normal cellular physiology—a condition known as haploinsufficiency—which frequently occurs in stoichiometric structural proteins, dosage-sensitive transcription factors (e.g., *PAX6* in aniridia), or rate-limiting cell-surface receptors (such as the LDL receptor *LDLR* in familial hypercholesterolemia).
Incomplete Dominance, Codominance, and Pleiotropy Across Biological Scales
Furthermore, whether an allele is classified as dominant, incompletely dominant (semidominant), or codominant depends entirely on the level of biological organization at which the phenotype is measured:
- Incomplete Dominance (Semidominance): The heterozygote (*A*1*A*2) displays a quantitative intermediate phenotype between the two homozygotes because the phenotypic readout is linearly proportional to gene dosage. In snapdragons (*Antirrhinum majus*), homozygotes for the functional anthocyanin synthase allele (*CRCR*) produce deep red petals, null homozygotes (*CWCW*) produce white petals, and heterozygotes (*CRCW*) produce 50% pigment concentration, yielding pink petals.
- Codominance: Both alleles in a heterozygote are fully, simultaneously, and independently expressed as distinct molecular structures. In the human ABO blood group system (located at chromosome 9q34.2), the *IA* allele encodes an α-1,3-N-acetylgalactosaminyltransferase that attaches N-acetylgalactosamine to the H antigen on red blood cells; the *IB* allele (differing at 4 amino acid positions) encodes an α-1,3-galactosyltransferase that attaches D-galactose; and the *i* (*O*) allele contains a single-nucleotide deletion (c.261delG) causing a premature frameshift stop codon. An *IAIB* heterozygote expresses both active glycosyltransferases and displays both A and B carbohydrate antigens on every erythrocyte (codominance), whereas both *IA* and *IB* show complete dominance over the null *i* allele.
- Scale-Dependent Dominance (Sickle-Cell Hemoglobin): Consider the human β-globin gene (*HBB*) on chromosome 11p15.4, where the wild-type HbA allele encodes glutamate at position 6 (GAG) and the sickle-cell HbS allele carries a single A → T transversion encoding valine (GTG, p.Glu6Val). In an HbA/HbS heterozygote (sickle-cell trait):
- At the Organismal Clinical Level (Sea Level): HbA is completely dominant over HbS; heterozygotes do not suffer spontaneous hemolytic anemia or vaso-occlusive crises.
- At the Physiological Stress / Altitude Level: HbA and HbS show incomplete dominance; under severe hypoxia or high altitude, a subset of red blood cells sickles, and heterozygotes show intermediate resistance to *Plasmodium falciparum* malaria (heterozygote advantage / overdominance).
- At the Molecular / Protein Electrophoresis Level: HbA and HbS are strictly codominant; both βA and βS globin chains are synthesized in roughly equal (~60:40) quantities within every single red blood cell and migrate as two distinct bands on a protein gel.
Multiple Allelism and Population Genetics: How Do Allele Frequencies Behave in Gene Pools?
Although any single diploid individual can carry at most two alleles at a given autosomal locus, an interbreeding population of millions of individuals can harbor dozens or thousands of distinct alleles at that same locus—a phenomenon termed multiple allelism. When at least two alleles at a locus exist in a population at a frequency greater than 1% (0.01), the locus is defined as polymorphic.
- At the human *CFTR* locus, over 2,100 distinct mutant alleles have been cataloged clinically, leading to compound heterozygotes (individuals carrying two different recessive pathogenic alleles, such as *CFTR* p.Phe508del / p.Gly551Asp).
- The most polymorphic loci in vertebrate genomes are the Major Histocompatibility Complex (MHC) / Human Leukocyte Antigen (HLA) genes on chromosome 6p21: *HLA-B* alone has over 9,000 documented alleles in the human population, maintained by pathogen-driven balancing natural selection and heterozygote advantage.
In population genetics, formulated independently by Godfrey Harold Hardy and Wilhelm Weinberg in 1908, the genetic composition of a population is quantified by its allele frequencies (*p* and *q* for a biallelic locus, or *p*1, *p*2, ..., *p*k for multiple alleles):
Under the Hardy–Weinberg Equilibrium (HWE) assumptions—an infinitely large panmictic (randomly mating) population free from mutation, migration (gene flow), natural selection, and random genetic drift (governed by effective population size *N*e)—both allele frequencies (*p*, *q*) and diploid genotype frequencies remain constant from generation to generation according to the binomial expansion:
This principle immediately refutes the fallacy that dominant alleles must eventually sweep a population to 100% frequency: the dominant human allele for brachydactyly (shortened fingers) or Huntington's disease remains below *p* < 0.0001 in human populations, whereas the recessive *O* blood group allele (*i*) is the most common allele globally (*q* ≈ 0.63 worldwide, and >0.95 in Indigenous South American populations).
Frequently Asked Scientific Questions
What is the exact difference between a gene, a locus, and an allele?
A locus is the fixed physical street address (chromosomal coordinate) on a chromosome (e.g., human chromosome 11p15.4). A gene is the functional hereditary unit residing at that address that encodes a specific RNA or protein (e.g., the *HBB* gene encoding β-globin). An allele is a specific sequence flavor or variant of that gene (e.g., the wild-type HbA allele, the sickle-cell HbS allele, or the HbC allele).
Why can a dominant mutation be rare in a population while a recessive allele is very common?
Dominance describes how two alleles interact physiologically inside a single heterozygous individual (*A/a*), whereas allele frequency (*p* or *q*) in a population is governed by evolutionary fitness (natural selection) and genetic drift. If a dominant allele reduces reproductive fitness (such as achondroplasia dwarfism), selection keeps its frequency near the mutation rate (*p* ≈ 10−5); if a recessive allele confers high fitness, its frequency approaches 100%.
How does a dominant-negative (antimorphic) allele differ from haploinsufficiency?
Both cause dominant genetic traits from a single mutant allele copy in heterozygotes, but by different mechanisms. In haploinsufficiency, the mutant allele is a simple null (amorph) that produces zero protein, and the remaining 50% wild-type protein is simply not enough for normal function. In a dominant-negative (antimorphic) mutation, the mutant allele synthesizes a defective subunit that physically co-assembles with wild-type subunits into multimeric complexes (like homo-tetrameric p53 or triple-helical Type I collagen), crippling up to 75%–93.75% of all assembled complexes.